In the last month, two patents were awarded to inventors from the Center for Computational Imaging and Personalized Diagnostics (CCIPD): “Predicting recurrence in early stage non-small cell lung cancer (NSCLC) using spatial arrangement of clusters of tumor infiltrating lymphocytes and cancer nuclei”, and “Hough transform-based vascular network disorder features on baseline fluorescein angiography scans predict response to anti-VEGF therapy in diabetic macular edema”.